Molecular Genetics Thalassemia lab of The Cyprus Institute of Neurology and Genetics transforms testing with NGS
In this case study, Dr. Papasavva describes her laboratory’s journey from traditional thalassemia testing to state-of-the-art NGS technology and what a difference this has made in their daily work.
- Instead of running on average three tests per
patient, they now only run one and get a
comprehensive analysis - The workflow is fast and simple; with just one
tube we can test most of the thalassemias
almost 100% - They can save on average 4 weeks for a patient
waiting for their diagnosis
Get access to the case study by filling out the form below
Related content
View allDevyser receives MDSAP certification for Brazil
Read More
Devyser publishes annual report for 2023
Devyser´s annual report 2023 has today been published on the company´s website. The report is...
Read More
Devyser achieves breakthrough in the US with cystic fibrosis NGS test
Devyser has secured a CFTR NGS proposal with UNC Hospitals. The proposal with UNC Hospitals is...
Read More